雲維股份(600725.SH):擬出資3000萬元設立全資子公司
格隆匯11月5日丨雲維股份(600725.SH)公佈,為進一步促進公司轉型升級,提高運營效率,發揮經營團隊活力,公司擬以自有資金通過現金方式出資3000萬元設立全資子公司曲靖能投雲維營銷有限公司,佔註冊資本的100%。
經營範圍包括化工及化纖材料、水泥、氧氣產品的銷售,機械,機電,五金,金屬材料的批發、零售、代購代銷;汽車貨運運輸、汽車維修經營;經營企業自產產品及技術的出口業務,進口本企業所需的原輔材料、儀器儀表、機械設備及技術,純鹼、氯化銨銷售,化肥銷售,煤炭銷售;焦炭銷售;石油焦銷售;豆粕銷售;鐵礦石銷售;非金屬礦及製品、銅礦石、控制櫃的銷售,從事商業經紀業務,廢舊金屬製品回收與銷售。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.